Hermetica Superfood Encyclopedia
The Short Answer
Ficus religiosa contains β-sitosteryl-D-glucoside, kaempferol, myricetin, lupeol, and tannins that exert hypoglycemic, antioxidant, and anti-inflammatory effects by modulating MAPK signaling, upregulating antioxidant enzymes (catalase, glutathione peroxidase), and inhibiting nitric oxide production. In animal models, aqueous bark extract at 200 mg/kg produced dose-dependent improvements in catalase and glutathione peroxidase activity in diabetic rats, while root bark β-sitosteryl-D-glucoside demonstrated oral hypoglycemic activity in alloxan-diabetic rabbits, though no human clinical trials have established efficacious doses.
CategoryHerb
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordFicus religiosa benefits
Sacred Fig — botanical close-up
Health Benefits
**Antidiabetic Activity**
β-sitosteryl-D-glucoside isolated from root and stem bark exhibits peroral hypoglycemic effects in alloxan-diabetic rabbits and pituitary-diabetic rat models, likely through enhanced peripheral glucose uptake and modulation of insulin signaling pathways.
**Antioxidant Enzyme Upregulation**
Aqueous bark extract dose-dependently upregulates catalase (CAT) and glutathione peroxidase (GSH-Px) in diabetic rats at 200 mg/kg, reducing oxidative stress burden through preservation of the glutathione redox cycle and attenuation of superoxide radical accumulation.
**Anti-inflammatory and Neuroprotective Effects**
Methanolic leaf extract suppresses nitric oxide production and proinflammatory cytokine release in LPS-stimulated microglial cells via inhibition of the mitogen-activated protein kinase (MAPK) pathway, suggesting potential utility in neuroinflammatory conditions.
**Anticancer Potential**
Crude plant extracts demonstrate in vitro cytotoxicity against cancer cell lines with an IC50 of 4.8 μg/mL by trypan blue exclusion assay and growth inhibition up to 500 μg/mL, with flow cytometric evidence of G2/M phase cell cycle arrest linked to pro-apoptotic signaling.
**Thrombolytic Activity**
Solvent extracts of Ficus religiosa exhibit thrombolytic activity reaching 60.59 ± 1.41% clot lysis compared to the standard streptokinase at 66.38 ± 0.90%, suggesting fibrinolytic compounds within the plant matrix with potential cardiovascular applications.
**Antiasthmatic Properties**
Traditional Ayurvedic applications for asthma are supported by the presence of lupeol, beta-amyrin, and phytosterols in leaf and bark extracts that modulate inflammatory mediators relevant to airway hyperresponsiveness, though direct mechanistic bronchospasm studies remain limited.
**Nutritional and Amino Acid Support**: Ripe fruits contain approximately 4
9% protein with essential amino acids including isoleucine and phenylalanine, alongside serotonin and high concentrations of flavonols—kaempferol at 160.8 mg/kg and myricetin at 694 mg/kg—contributing to antioxidant and neuromodulatory nutritional value.
Origin & History
Natural habitat
Ficus religiosa is native to the Indian subcontinent and Southeast Asia, ranging from Nepal, India, and Sri Lanka eastward through Myanmar, Thailand, and southwestern China. It thrives in tropical and subtropical climates at elevations up to 1,500 meters, preferring well-drained loamy soils and full sun exposure, often found growing near temples, riverbanks, and disturbed forest margins. The tree has been cultivated for millennia across South and Southeast Asia, where it is revered as the Bodhi tree under which the Buddha attained enlightenment, ensuring its propagation around religious sites throughout the region.
“Ficus religiosa, called Peepal or Bodhi tree in India and Ashvattha in Sanskrit, occupies one of the most prominent positions in Ayurvedic medicine, referenced in classical texts including the Charaka Samhita and Sushruta Samhita for its applications in treating diabetes (prameha), skin diseases, dysentery, asthma, and wound healing across at least two millennia of documented use. The tree holds supreme religious significance in Hinduism, Buddhism, and Jainism—the Buddha is traditionally said to have attained enlightenment beneath a Ficus religiosa at Bodh Gaya, India, circa 500 BCE—ensuring its preservation and widespread cultivation across the Indian subcontinent and Southeast Asia. Traditional preparations documented in Ayurveda include bark decoctions for glycemic management, leaf paste poultices for wound care and skin inflammation, fruit powders for nutritional support, and latex applications for skin conditions and toothache. The tree's ubiquity in village centers and temple grounds throughout South Asia has maintained an unbroken chain of ethnomedicinal use in rural communities, particularly for asthma management via bark decoctions and anti-inflammatory bark pastes applied topically.”Traditional Medicine
Scientific Research
The evidence base for Ficus religiosa consists entirely of in vitro cell culture studies, animal model experiments, and phytochemical characterization reports; no peer-reviewed human clinical trials with defined sample sizes, randomization, or effect size reporting have been identified. In vitro anticancer studies demonstrated IC50 values of 4.8 μg/mL with trypan blue exclusion and G2/M arrest by flow cytometry, while anti-inflammatory assays in LPS-stimulated BV-2 microglia measured NO inhibition and cytokine suppression by ELISA, providing mechanistic but not translational evidence. Animal hypoglycemic studies used alloxan-diabetic rabbits and pituitary-diabetic rats receiving root bark extract, and antioxidant studies employed diabetic rats at 200 mg/kg aqueous bark extract, but sample sizes, statistical power, and blinding protocols were not reported in available literature, limiting confidence in effect estimates. The thrombolytic study reported clot lysis of 60.59 ± 1.41% versus streptokinase at 66.38 ± 0.90%, representing a promising in vitro signal, but the absence of ex vivo or in vivo validation means clinical translation cannot be assumed.
Preparation & Dosage
Traditional preparation
**Aqueous Bark Decoction (Traditional)**
5–15 g dried bark equivalent per day in divided doses
Bark is boiled in water at a ratio of approximately 1:8 (w/v), filtered, and consumed; traditional Ayurvedic doses are not formally standardized but typically range from .
**Methanolic/Ethanolic Extract (Research Grade)**
200 mg/kg body weight (aqueous bark)
Prepared by reflux or shaker extraction using 70–95% methanol or ethanol, yielding highest phenolic and flavonoid content; research concentrations ranged from 50–500 μg/mL in vitro, with animal dosing at .
**Bark Powder (Traditional)**
3–6 g/day as bark churna (powder) in honey or warm water for glycemic support
Dried and powdered stem or root bark consumed orally; no human-validated dose exists, but Ayurvedic texts reference .
**Fruit Consumption (Nutritional)**
8 mg/kg), myricetin (694 mg/kg), and approximately 4
Ripe fruits consumed fresh or dried provide kaempferol (160..9% protein with essential amino acids; no standardized supplemental dosage is established.
**Leaf Extract**
Methanolic leaf extract studied primarily in vitro for anti-inflammatory and neuroprotective effects; no standardized dose or commercial formulation is currently validated.
**Standardization**
No commercial extract standardization to specific marker compounds (e.g., β-sitosteryl-D-glucoside, myricetin) has been established; products claiming Ficus religiosa content should be treated with caution regarding potency and consistency.
Nutritional Profile
Ficus religiosa fruits contain approximately 4.9% protein by weight, notable for essential amino acids isoleucine and phenylalanine, as well as the neuroactive compound serotonin, making the fruit nutritionally distinct among Ficus species. Flavonol concentrations in fruit are substantial: myricetin at 694 mg/kg (the dominant flavonol), kaempferol at 160.8 mg/kg, and quercetin at lower unspecified concentrations, contributing significant antioxidant capacity. Leaves contain 2.8% phytosterols (stigmasterol, campesterol, 28-isofucosterol, sitosterol), 28.5% triterpene alcohols (lupeol, alpha-amyrin, beta-amyrin), 7.9% aliphatic alcohols (n-hexacosanol, n-octacosanol), and 7.1% hydrocarbons, reflecting a lipophilic-rich fraction with potential membrane-stabilizing and anti-inflammatory bioavailability considerations. Bark contains 8.7% tannins and yields β-sitosteryl-D-glucoside, methyl oleanolate, lanosterol, stigmasterol, lupen-3-one, and vitamin K; phenolic and flavonoid content is highest in methanol extracts, with DPPH radical scavenging IC50 of 24.52 μg/mL suggesting strong in vitro antioxidant bioavailability, though gastrointestinal absorption and systemic bioavailability in humans have not been characterized.
How It Works
Mechanism of Action
The hypoglycemic mechanism of β-sitosteryl-D-glucoside from root bark is attributed to enhanced peripheral glucose disposal and possible stimulation of residual pancreatic beta-cell function, as demonstrated in alloxan- and pituitary-damaged diabetic animal models. Anti-inflammatory activity operates through suppression of the MAPK signaling cascade (including ERK, JNK, and p38 subpathways) in activated microglia, reducing downstream transcription of inducible nitric oxide synthase (iNOS) and proinflammatory cytokines such as TNF-α and IL-6, as characterized by ELISA-based cytokine quantification. Antioxidant effects are mediated by phenolic compounds—including quercetin, myricetin, kaempferol, and tannins (8.7% in bark)—that scavenge reactive oxygen species directly (DPPH IC50 24.52 μg/mL; NO IC50 463.45 μg/mL) and indirectly by upregulating endogenous antioxidant enzymes CAT and GSH-Px, possibly through Nrf2/ARE pathway activation enabled by improved NADPH availability and reduced glutathione depletion. Anticancer mechanisms involve G2/M cell cycle arrest mediated by disruption of cyclin B1/CDK1 complexes and activation of intrinsic apoptotic pathways, as evidenced by flow cytometric analysis of treated cancer cell populations.
Clinical Evidence
No controlled human clinical trials have been conducted on Ficus religiosa extracts for any indication, including asthma, diabetes, or cancer, as of the available research literature. Preclinical animal studies suggest antidiabetic efficacy of β-sitosteryl-D-glucoside and aqueous bark extract in chemically induced diabetic rodent and rabbit models, with dose-dependent enzyme modulation observed at 200 mg/kg, but these findings have not been replicated in human pharmacokinetic or pharmacodynamic studies. In vitro outcomes, while mechanistically informative—particularly the MAPK pathway inhibition and G2/M cell cycle arrest data—cannot be extrapolated to clinical effect sizes without phase I/II human dose-escalation trials. Confidence in the therapeutic use of Ficus religiosa for any specific human health condition must therefore be rated as low, and the ingredient remains in the investigational/traditional use category pending human trial data.
Safety & Interactions
Formal toxicological studies, including acute, subacute, and chronic toxicity assessments in humans or animals, have not been reported in the available peer-reviewed literature for Ficus religiosa extracts, and no established maximum safe dose or NOAEL (No Observed Adverse Effect Level) exists for any plant part or extract form. Animal studies employing aqueous bark extract at 200 mg/kg and in vitro experiments at concentrations up to 500 μg/mL have not reported overt toxic findings, but the absence of toxicity reporting does not constitute a safety endorsement, particularly for long-term human use. Theoretical drug interactions exist given the documented hypoglycemic activity of β-sitosteryl-D-glucoside, which may potentiate the effects of antidiabetic medications (sulfonylureas, biguanides, insulin) and increase hypoglycemia risk; the thrombolytic activity observed in vitro also raises theoretical concern for additive bleeding risk with anticoagulant and antiplatelet agents. Pregnancy and lactation safety data are entirely absent; use during pregnancy, lactation, or in pediatric populations cannot be recommended without controlled safety data, and individuals with latex allergy should exercise caution given the latex-producing nature of Ficus species.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Ficus religiosa L.Peepal treeBodhi treeAshvatthaSacred figPipalBo tree
Frequently Asked Questions
Can Ficus religiosa lower blood sugar in humans?
Human clinical trials for Ficus religiosa's antidiabetic effects do not yet exist; current evidence is limited to animal studies using alloxan-diabetic rabbits and pituitary-diabetic rats, where root bark extract containing β-sitosteryl-D-glucoside produced measurable hypoglycemic responses. Aqueous bark extract at 200 mg/kg also upregulated antioxidant enzymes catalase and glutathione peroxidase in diabetic rats, suggesting an indirect mechanism of glycemic protection through reduced oxidative stress. Until human pharmacokinetic and dose-finding trials are completed, Ficus religiosa cannot be recommended as a validated antidiabetic therapy, and individuals with diabetes should not substitute it for prescribed medications.
What are the main bioactive compounds in Ficus religiosa?
Ficus religiosa contains a diverse phytochemical profile that varies by plant part: bark provides β-sitosteryl-D-glucoside, tannins (8.7%), lanosterol, stigmasterol, lupen-3-one, and vitamin K; leaves supply phytosterols (2.8%), including stigmasterol and sitosterol, along with triterpene alcohols lupeol, alpha-amyrin, and beta-amyrin (28.5% combined), and aliphatic alcohols. Fruits are particularly rich in the flavonols myricetin (694 mg/kg) and kaempferol (160.8 mg/kg), plus quercetin, serotonin, and essential amino acids isoleucine and phenylalanine. Methanol extracts across plant parts show strong antioxidant activity (DPPH IC50 24.52 μg/mL), attributable primarily to the combined phenolic and flavonoid fraction.
Is Ficus religiosa safe to consume, and are there drug interactions?
Formal human safety studies for Ficus religiosa are absent from the published literature; animal and in vitro studies have not reported overt toxicity, but this does not establish human safety for any specific dose or duration. Theoretical drug interactions are a concern: its documented hypoglycemic activity could potentiate antidiabetic medications (insulin, metformin, sulfonylureas), raising hypoglycemia risk, and in vitro thrombolytic activity suggests potential additive effects with anticoagulants such as warfarin or antiplatelet drugs like aspirin. Pregnant and breastfeeding individuals should avoid use entirely until controlled human safety data are available.
How is Ficus religiosa traditionally prepared in Ayurvedic medicine?
In Ayurveda, the most common preparation involves decocting dried bark in water (approximately 1:8 w/v ratio), filtering, and consuming the liquid for conditions including diabetes (prameha), asthma, and skin inflammation, with classical texts referencing 3–6 g of bark churna (powder) mixed with honey or warm water. Leaf pastes prepared by crushing fresh leaves with water are applied topically to wounds and inflamed skin, while latex from the tree has been used for dental pain and dermatological conditions. Fruits are consumed fresh or dried for their nutritional and mild antioxidant properties, and polyherbal Ayurvedic formulations frequently combine Ficus religiosa bark with other Ficus species (F. benghalensis) and Terminalia chebula in Rasayana tonics.
Does Ficus religiosa have anticancer properties?
In vitro studies report that crude Ficus religiosa extracts exhibit cytotoxic activity against cancer cell lines with an IC50 of 4.8 μg/mL measured by trypan blue exclusion assay, with growth inhibition observed at concentrations up to 500 μg/mL. Flow cytometric analysis has demonstrated G2/M phase cell cycle arrest in treated cancer cells, suggesting interference with cyclin B1/CDK1-mediated mitotic progression and activation of apoptotic signaling. However, these are early-stage laboratory findings with no animal tumor model validation or human trial data, so any clinical anticancer claims for Ficus religiosa remain entirely unsupported and speculative at this stage of research.
What is the most bioavailable form of Ficus religiosa for blood sugar support?
Aqueous bark extracts and standardized preparations appear to offer superior bioavailability compared to whole plant material, as studies isolating β-sitosteryl-D-glucoside from root and stem bark demonstrated measurable hypoglycemic effects in animal models. The specific extraction method affects compound concentration and peripheral glucose uptake efficiency. Standardized extracts that preserve the active phytosteryl glucosides are likely more effective than crude preparations, though direct human bioavailability studies are limited.
Does Ficus religiosa enhance the body's own antioxidant defenses?
Yes, aqueous bark extracts of Ficus religiosa dose-dependently upregulate endogenous antioxidant enzymes including catalase (CAT) and glutathione-related pathways, rather than simply providing exogenous antioxidants. This enzymatic upregulation may provide sustained cellular protection beyond the extract's direct antioxidant activity. This mechanism suggests potential value for conditions involving oxidative stress-related cellular damage.
Who would benefit most from Ficus religiosa supplementation for metabolic health?
Individuals with prediabetes or type 2 diabetes may benefit most, as research demonstrates enhanced peripheral glucose uptake and insulin signaling modulation in diabetic animal models. Those with metabolic syndrome or elevated oxidative stress markers could also be candidates, given the dual antidiabetic and antioxidant enzyme-upregulating effects. However, current evidence is primarily from animal studies, so human clinical outcomes remain to be established in robust trials.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w sacred-fig-ficus-religiosa-l curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
